BioWorld Today Contributing Writer   If you do a web search on the term “cancer cure,” you’ll get pages and pages of conspiracy theories, alternative medicine sites, and home-cooked “natural” remedies. Some of them, like baking soda and maple syrup (I kid you not) are probably harmless. Some of them cross the line into deception. But what you won’t find, as you click through pages and pages of snake oil, is a legitimate, mainstream medical site with information on curing cancer. The focus is on “controlling” the disease, “inducing” remission, maintaining “complete response,” increasing “overall survival,” and...

It looked Monday as if two of biotech’s long-suffering names might finally be biting the dust. Genta Inc. threw in the towel on beleaguered antisense drug Genasense (oblimersen sodium), after a final analysis of a Phase III melanoma trial – and a previous Phase III melanoma trial, and a Phase III chronic lymphocytic leukemia trial, and a Phase III multiple myeloma trial, and a melanoma approval bid, and a CLL approval bid, and a second CLL approval bid – failed. Meanwhile La Jolla Pharmaceutical Co., which already abandoned lupus drug Riquent (abetimus sodium) after years of mixed data and failed...